These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31270892)

  • 1. Case of anti-Hu antibody-mediated encephalopathy associated with ovarian cancer.
    Yoshida H; Furugori M; Kanatsuka Y; Yamaguchi S; Shigeta H
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1948-1951. PubMed ID: 31270892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study.
    Li J; Lin W
    Medicine (Baltimore); 2018 May; 97(18):e0649. PubMed ID: 29718880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review.
    Dai YL; Xiao L; Pan Z; He GQ; Gao J; Guo X; Huang Z
    Medicine (Baltimore); 2024 May; 103(19):e38148. PubMed ID: 38728479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in Paraneoplastic Neurological Syndrome].
    Kawachi I
    Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
    Raibagkar P; Ho D; Gunturu KS; Srinivasan J
    J Neuroimmunol; 2020 Apr; 341():577184. PubMed ID: 32058173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms.
    Rauer S; Czygan M; Kaiser R
    J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.
    Lladó A; Mannucci P; Carpentier AF; Paris S; Blanco Y; Saiz A; Delattre JY; Graus F
    Neurology; 2004 Nov; 63(10):1947-9. PubMed ID: 15557520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropathy associated with paraneoplastic neurological syndrome].
    Mitsui Y; Kusunoki S
    Brain Nerve; 2010 Apr; 62(4):387-93. PubMed ID: 20420179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.
    de Jongste AH; van Gelder T; Bromberg JE; de Graaf MT; Gratama JW; Schreurs MW; Hooijkaas H; Sillevis Smitt PA
    Neuro Oncol; 2015 Jan; 17(1):145-50. PubMed ID: 24994790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
    Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
    J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
    Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
    Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.
    de Jongste AH; de Graaf MT; Martinuzzi E; van den Broek PD; Kraan J; Lamers CH; Mallone R; Gratama JW; Sillevis Smitt PA
    Neuro Oncol; 2012 Jul; 14(7):841-8. PubMed ID: 22591661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic anti-HU syndrome associated with uterine tumor.
    Côté-Mantha E; Savard M
    Can J Neurol Sci; 2012 Mar; 39(2):254-5. PubMed ID: 22506291
    [No Abstract]   [Full Text] [Related]  

  • 16. Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions.
    Verschuuren J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):742. PubMed ID: 18559456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Steroid responsive anti-Hu-associated paraneoplastic encephalitis with bilateral frontal lobe lesions].
    Yamamoto A; Tsuda K; Maeda R; Nakano K; Mori K; Arita N; Yoshikawa H
    Rinsho Shinkeigaku; 2013; 53(4):273-7. PubMed ID: 23603540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic neurologic syndromes. Diagnostic and pathogenetic significance of autoantibodies].
    Kaiser R
    Nervenarzt; 1999 Aug; 70(8):688-701. PubMed ID: 10483569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes.
    Blaes F; Klotz M; Funke D; Strittmatter M; Kraus J; Kaps M
    Eur J Neurol; 2002 Jul; 9(4):369-72. PubMed ID: 12099920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic total plasma exchange in a child with neuroblastoma-related anti-Hu syndrome.
    van Vuurden DG; Plötz FB; de Jong M; Bokenkamp A; van Wijk JA
    Pediatr Nephrol; 2005 Nov; 20(11):1655-6. PubMed ID: 16133055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.